Medirom (MRM) director Uekusa Yoshio discloses 28,837 ADS ownership in Form 3

Rhea-AI Filing Summary

Medirom Healthcare Technologies Inc. director Uekusa Yoshio filed an initial ownership report showing a direct holding of common shares. The filing states this position is represented by 28,837 American Depositary Shares. This Form 3 does not report any new purchase or sale, only existing ownership.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Uekusa Yoshio

Role null

Type	Security	Shares	Price	Value
holding	Common Shares	--	--	--

Holdings After Transaction: Common Shares — 28,837 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Director ADS holding: 28,837 American Depositary Shares

1 metrics

Director ADS holding 28,837 American Depositary Shares Initial beneficial ownership reported on Form 3

Key Terms

Form 3, American Depositary Shares, beneficial ownership

3 terms

Form 3 regulatory

"The purpose is to disclose initial beneficial ownership when Uekusa Yoshio became a reporting insider"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

American Depositary Shares financial

"Represents common shares held by the reporting person underlying 28,837 American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

beneficial ownership financial

"disclose initial beneficial ownership when Uekusa Yoshio became a reporting insider"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 06/09/2026 - 06:27 AM Accepted by SEC EDGAR 06/09/2026 - 06:27 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Uekusa Yoshio

(Last) (First) (Middle)

2-3-1 DAIBA

(Street)

MINATO-KU TOKYO JAPAN 135-0091

(City) (State) (Zip)

JAPAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/29/2026

3. Issuer Name and Ticker or Trading Symbol
Medirom Healthcare Technologies Inc. [ MRM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	28,837(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents common shares held by the reporting person underlying 28,837 American Depositary Shares.

	By: /s/ Yoshio Uekusa, Name: Yoshio Uekusa	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Medirom (MRM) director Uekusa Yoshio report in this Form 3?

The Form 3 shows that director Uekusa Yoshio holds common shares of Medirom Healthcare Technologies Inc., represented by 28,837 American Depositary Shares. This is an initial ownership disclosure, not a report of a new trade or change in position.

Did Uekusa Yoshio buy or sell Medirom (MRM) shares in this filing?

No, the filing does not show a buy or sell transaction. It is a Form 3, which discloses an insider’s existing holdings when they first become subject to reporting, rather than recording a new purchase or sale event.

How many Medirom (MRM) American Depositary Shares does the director hold?

The director’s reported position is represented by 28,837 American Depositary Shares of Medirom Healthcare Technologies Inc. These ADS correspond to the underlying common shares referenced in the filing’s footnote as the basis for the reported ownership.

Is the Medirom (MRM) director’s ownership held directly or indirectly?

The filing classifies the director’s holdings as direct ownership. This means the shares, represented by the 28,837 American Depositary Shares, are held directly in the reporting person’s name rather than through an intermediary entity such as a trust or partnership.

What is the purpose of Medirom (MRM) filing this Form 3 for Uekusa Yoshio?

The purpose is to disclose initial beneficial ownership when Uekusa Yoshio became a reporting insider at Medirom Healthcare Technologies Inc. It establishes the baseline share position, which future Forms 4 or 5 would update if transactions occur.